By Dr Chun Tang — MBChB (Manchester), MRCGP, MBA · Practising NHS & Private GP · Founder, Little Ox

ADHD, Mitochondria and NAD+: What the Research Shows — and What It Doesn't

Adult ADHD is one of the fastest-growing diagnoses in UK general practice. In my own clinic, I see more adults seeking assessment — and more receiving diagnoses — than at any point in my 26 years of practice. The waiting lists for NHS adult ADHD assessment are running to years in many areas. Thousands of people are managing symptoms without a formal diagnosis at all.

In this context, it's not surprising that people are looking for every available tool to support focus, mental energy and cognitive stamina. NMN is increasingly being discussed in ADHD communities, and people are asking me whether there's any science behind it.

The honest answer is: there is a genuine and interesting biological connection — but the clinical evidence is at an early stage. I want to explain both things clearly, because this matters. If you have ADHD, you deserve accurate information rather than supplements oversold on a thin research base.

What ADHD Actually Is — The Biology That's Often Missed

ADHD is a neurodevelopmental condition, not simply a habit or a character trait. It involves structural and functional differences in specific brain regions — most significantly the prefrontal cortex (PFC), which governs executive function, working memory, impulse control and sustained attention.

The neurotransmitter picture is complex. The dopamine hypothesis of ADHD — the idea that reduced dopaminergic signalling underlies the condition — has been the dominant model for decades, and it's supported by substantial evidence. The effectiveness of stimulant medications (methylphenidate, amphetamine derivatives) that increase dopamine and norepinephrine availability is one of the strongest lines of supporting evidence. A comprehensive review published in Frontiers in Psychiatry in November 2024 examined over 40 years of research on the dopamine-ADHD connection and concluded the evidence is robust, if more nuanced than early models suggested.

But there's a second layer to ADHD biology that receives less attention: mitochondrial function.

ADHD and Mitochondrial Dysfunction — The Emerging Research

The prefrontal cortex is one of the most metabolically demanding regions of the brain. It requires consistent, reliable energy production to maintain the sustained neural firing that underlies executive function. When that energy supply is compromised — whether through mitochondrial dysfunction, oxidative stress or reduced cellular metabolism metabolism — PFC function suffers in ways that look very similar to ADHD symptoms.

Research published in 2024 and 2025 has made the mitochondrial connection significantly clearer:

A 2024 review in Brain Sciences titled "Mitochondrial Dysfunction in Attention Deficit Hyperactivity Disorder" established that disrupted mitochondrial homeostasis is a consistent feature across ADHD models. The review identified multiple mechanisms including impaired oxidative phosphorylation, increased oxidative stress and mitophagy dysregulation in ADHD.

A study published in the International Journal of Molecular Sciences in November 2025 found consistently altered expression of mitochondrial NADH dehydrogenase complex I genes (ND1–ND6) in the prefrontal cortex across multiple ADHD animal models. These are the genes directly responsible for NADH-to-NAD+ conversion in the mitochondrial electron transport chain — the central energy-producing process that NAD+ supports.

Critically, mutations in the mitochondrial gene NDUFAF2 — which codes for a component of NADH Complex I — have been directly identified in children with ADHD. This is not a speculative link: it is a documented genetic finding connecting ADHD susceptibility to the mitochondrial NAD+ metabolism pathway.

Methylphenidate (Ritalin), the most widely prescribed ADHD medication, has been shown to maintain mitochondrial homeostasis by increasing mitochondrial regulatory proteins and improving cellular metabolism production. The fact that the most effective ADHD treatment works partly through mitochondrial mechanisms is significant context for why mitochondrial energy support is a legitimate area of interest.

Where NAD+ and NMN Come In

NAD+ (Nicotinamide Adenine Dinucleotide) is the central molecule in mitochondrial energy production. The electron transport chain — the process by which mitochondria produce ATP from glucose — requires NAD+ as its primary electron carrier. Without adequate NAD+, mitochondria cannot produce energy efficiently.

NMN (Nicotinamide Mononucleotide) is a direct precursor to NAD+. When taken orally at a dose of 500mg, NMN raises blood and cellular NAD+ levels — this has been confirmed in multiple human clinical trials. The question for ADHD is whether raising NAD+ levels might support the mitochondrial energy supply that prefrontal cortex function depends on.

The mechanistic case is biologically plausible:

• ADHD involves mitochondrial dysfunction in the PFC — established by multiple 2024–2025 studies
• Mitochondrial function depends on adequate NAD+ — fundamental biochemistry
• NMN raises NAD+ levels — confirmed in human trials
• Therefore NMN may support the cellular metabolism substrate that ADHD brains struggle to utilise efficiently

This is mechanistic reasoning, not a clinical trial finding. I want to be precise about that distinction.

What the Direct Evidence Does and Doesn't Show

There are currently no completed human clinical trials testing NMN specifically in ADHD populations. This is the honest position, and it matters.

What we do have:

• Human trials confirming NMN raises NAD+ levels reliably at 500mg doses
• Animal model evidence that NAD+ restoration improves mitochondrial function in brain tissue
• Human trial evidence that NMN improves recovery and overnight routine — highly relevant since sleep dysregulation is near-universal in ADHD and dramatically worsens symptoms
• A 2024 clinical trial showing NMN improved sustained energy and reduced fatigue — the subjective experience that many adults with ADHD describe as "running out of battery" by mid-afternoon
• Strong mechanistic research linking ADHD directly to mitochondrial NAD+ pathway dysfunction

What we don't have: a randomised controlled trial showing NMN improves ADHD-specific outcomes (attention, executive function, impulsivity) in a diagnosed ADHD population. That research does not yet exist.

The Sleep Connection — Probably More Important Than You Think

If there's one area where NMN's evidence base intersects most clearly with ADHD, it's sleep.

Sleep dysregulation in ADHD is well-documented and goes beyond simple "not being tired at bedtime." Adults with ADHD commonly experience delayed sleep phase, difficulty initiating sleep, unrefreshing sleep patterns, and severe difficulty waking. Poor sleep dramatically worsens every ADHD symptom — attention, emotional regulation, impulsivity, working memory — creating a compounding cycle that medication often doesn't fully address.

A 2024 double-blind, randomised, placebo-controlled trial found that NMN supplementation significantly improved recovery and overnight routine in older adults, including reductions in daytime dysfunction. NAD+ is directly involved in regulating circadian clock genes — the molecular machinery that governs sleep-wake cycles. Restoring NAD+ may therefore support better circadian regulation alongside the specific sleep disruption patterns seen in ADHD.

This is not a cure for ADHD sleep problems. But for adults with ADHD who struggle with recovery and overnight routine, NMN's emerging sleep evidence is one of the more practically relevant areas of its research base.

What Else Supports Brain Energy in ADHD

In my clinical view, NMN should be one part of a broader approach to supporting brain energy and mitochondrial function in ADHD. The evidence base for the following is solid:

Magnesium — particularly magnesium glycinate. Magnesium deficiency is significantly more prevalent in people with ADHD than in the general population. Magnesium is an essential cofactor for over 300 enzymatic reactions, including those involved in ATP synthesis. It also supports GABA pathways that regulate sleep and anxiety — both critical in ADHD. Magnesium Glycinate is the most bioavailable form and is well-tolerated.

Exercise. Aerobic exercise is one of the most evidence-based non-pharmacological interventions for ADHD. It acutely raises dopamine and norepinephrine, and regular exercise increases mitochondrial density in the brain over time. NMN and exercise are complementary — NMN supports the mitochondrial energy machinery; exercise builds more of it.

Sleep hygiene. Given how dramatically sleep affects ADHD symptoms, prioritising consistent sleep is not optional. Magnesium glycinate in the evening, combined with NMN in the morning, represents the protocol I recommend to most patients interested in supplement support for energy and sleep.

Omega-3 fatty acids. The evidence for omega-3 (specifically DHA and EPA) in ADHD is more developed than for almost any other supplement — multiple meta-analyses show modest but consistent benefits for attention and impulsivity, particularly in children.

Who Might Consider NMN for ADHD Support?

Based on the current evidence, NMN is most relevant for:

• Adults with ADHD over 35 — where age-related NAD+ decline compounds the existing mitochondrial energy deficit associated with ADHD
• Adults with ADHD experiencing significant fatigue — particularly the "afternoon crash" pattern that many describe, where cognitive stamina depletes rapidly after midday
• Adults with ADHD and poor recovery and overnight routine — where NMN's sleep evidence is most directly relevant
• Adults who want to support their medication with cellular metabolism optimisation — NMN is not known to interact with standard ADHD medications, though as always, discuss with your prescribing doctor

NMN is not recommended as a first-line intervention for ADHD. Formal assessment, appropriate medication where indicated, behavioural strategies and sleep optimisation all take precedence.

The Protocol I'd Consider

As with any supplement, discuss with your GP before starting — particularly if you are taking prescribed ADHD medication or have any other health conditions.

Shop NMN Plus — from £9.99 → Shop Magnesium Glycinate — £9.99 →

---

This article is for informational purposes only and does not constitute medical advice. NMN is a food supplement, not a medicine, and is not intended to diagnose, treat, cure or prevent ADHD or any other condition. If you have ADHD or suspect you may have it, please seek formal assessment and advice from a qualified healthcare professional. Do not alter or stop any prescribed medication without consulting your doctor.